BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38847802)

  • 1. Enhancing CRISPR prime editing by reducing misfolded pegRNA interactions.
    Zhang W; Petri K; Ma J; Lee H; Tsai CL; Joung JK; Yeh JJ
    Elife; 2024 Jun; 12():. PubMed ID: 38847802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing CRISPR prime editing by reducing misfolded pegRNA interactions.
    Zhang W; Petri K; Ma J; Lee H; Tsai CL; Joung JK; Yeh JJ
    bioRxiv; 2023 Aug; ():. PubMed ID: 37645936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly efficient generation of isogenic pluripotent stem cell models using prime editing.
    Li H; Busquets O; Verma Y; Syed KM; Kutnowski N; Pangilinan GR; Gilbert LA; Bateup HS; Rio DC; Hockemeyer D; Soldner F
    Elife; 2022 Sep; 11():. PubMed ID: 36069759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A truncated reverse transcriptase enhances prime editing by split AAV vectors.
    Gao Z; Ravendran S; Mikkelsen NS; Haldrup J; Cai H; Ding X; Paludan SR; Thomsen MK; Mikkelsen JG; Bak RO
    Mol Ther; 2022 Sep; 30(9):2942-2951. PubMed ID: 35808824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prime editing efficiently generates W542L and S621I double mutations in two ALS genes in maize.
    Jiang YY; Chai YP; Lu MH; Han XL; Lin Q; Zhang Y; Zhang Q; Zhou Y; Wang XC; Gao C; Chen QJ
    Genome Biol; 2020 Oct; 21(1):257. PubMed ID: 33023639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line.
    Nguyen T; Aida T; Iijima-Yamashita Y; Tamai M; Nagamachi A; Kagami K; Komatsu C; Kasai S; Akahane K; Goi K; Inaba T; Sanada M; Inukai T
    Cancer Sci; 2024 Jun; 115(6):1924-1935. PubMed ID: 38549229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells.
    Petri K; Zhang W; Ma J; Schmidts A; Lee H; Horng JE; Kim DY; Kurt IC; Clement K; Hsu JY; Pinello L; Maus MV; Joung JK; Yeh JJ
    Nat Biotechnol; 2022 Feb; 40(2):189-193. PubMed ID: 33927418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prime Editing Guide RNA Design Automation Using PINE-CONE.
    Standage-Beier K; Tekel SJ; Brafman DA; Wang X
    ACS Synth Biol; 2021 Feb; 10(2):422-427. PubMed ID: 33464043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prime editing in mice with an engineered pegRNA.
    Salem AR; Bryant WB; Doja J; Griffin SH; Shi X; Han W; Su Y; Verin AD; Miano JM
    Vascul Pharmacol; 2024 Mar; 154():107269. PubMed ID: 38158001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Optimization of CRISPR Prime Editing System in Photoautotrophic Cells.
    Jiang Z; Abdullah ; Zhang S; Jiang Y; Liu R; Xiao Y
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of zebrafish models by CRISPR /Cas9 genome editing.
    Hruscha A; Schmid B
    Methods Mol Biol; 2015; 1254():341-50. PubMed ID: 25431076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of Prime Editing in Rice, Peanut, Chickpea, and Cowpea Protoplasts by Restoration of GFP Activity.
    Biswas S; Bridgeland A; Irum S; Thomson MJ; Septiningsih EM
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PrimeDesign software for rapid and simplified design of prime editing guide RNAs.
    Hsu JY; Grünewald J; Szalay R; Shih J; Anzalone AV; Lam KC; Shen MW; Petri K; Liu DR; Joung JK; Pinello L
    Nat Commun; 2021 Feb; 12(1):1034. PubMed ID: 33589617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prime editing: a search and replace tool with versatile base changes.
    Liu Y; Zhou XH; Huang SH; Wang XL
    Yi Chuan; 2022 Nov; 44(11):993-1008. PubMed ID: 36384993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements.
    Lattanzi A; Meneghini V; Pavani G; Amor F; Ramadier S; Felix T; Antoniani C; Masson C; Alibeu O; Lee C; Porteus MH; Bao G; Amendola M; Mavilio F; Miccio A
    Mol Ther; 2019 Jan; 27(1):137-150. PubMed ID: 30424953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the inherent auto-inhibitory interaction within the pegRNA enhances prime editing efficiency.
    Ponnienselvan K; Liu P; Nyalile T; Oikemus S; Maitland SA; Lawson ND; Luban J; Wolfe SA
    Nucleic Acids Res; 2023 Jul; 51(13):6966-6980. PubMed ID: 37246708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prime Editing: An Emerging Tool in Cancer Treatment.
    Sen D; Sarkar S; Mukhopadhyay P
    Mol Biotechnol; 2023 Apr; 65(4):509-520. PubMed ID: 36251123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly efficient prime editing by introducing same-sense mutations in pegRNA or stabilizing its structure.
    Li X; Zhou L; Gao BQ; Li G; Wang X; Wang Y; Wei J; Han W; Wang Z; Li J; Gao R; Zhu J; Xu W; Wu J; Yang B; Sun X; Yang L; Chen J
    Nat Commun; 2022 Mar; 13(1):1669. PubMed ID: 35351879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.
    Naeem M; Majeed S; Hoque MZ; Ahmad I
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.